PFE – Start with the roughly $12B in annual worldwide Lipitor sales and:
—Multiply by 0.55 for the US portion —Multiply by 1.7 to convert to a 20-month period —Multiply by 0.45 for the cash profit margin (gross margin net of selling expenses and taxes but excluding R&D, D&A, and corporate overhead)
You get about $5B of incremental cash with which to pay the dividend or use for other purposes.
Let’s talk biotech! “The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”